可溶性ST2是一种与患有基本高血压的患者的左心室缩和集中性缩相关的生物标志物
Xia Wang1,2, Shu-Jie Han1,2, Xiao-Li Wang1,2
1Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
American journal of hypertension
|August 13, 2024
概括
升高的可溶性刺激因子2 (sST2) 水平与基本高血压 (EH) 中的左心室缩 (LVH) 和集中性缩 (CH) 有关. 这种生物标志物可以帮助诊断和评估高血压心脏病的风险.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 高血压研究 高血压研究
背景情况:
- 升高的可溶性刺激因子2 (sST2) 与心血管疾病有关,反映了心肌纤维化和高.
- 在高血压性心脏病,特别是左心室缩 (LVH) 和几何重塑中sST2的作用仍然不太清楚.
- 基本高血压 (EH) 是心血管并发症的重要危险因素.
研究的目的:
- 在患有基本高血压 (EH) 的患者中调查sST2水平和左心室缩 (LVH) 之间的关系.
- 确定sST2与EH的左心室几何重塑的关联.
- 评估sST2作为高血压心脏病的潜在生物标志物.
主要方法:
- 招募了483名患有基本高血压 (年龄在18-80岁) 的患者队列.
- 测量了血清中的sST2水平.
- 进行了心声分析,以评估左心室质量,质量指数,LVH和几何重塑.
主要成果:
- 逐步的多重线性回归揭示了sST2,左心室 (LV) 质量和LV质量指数之间的显著关联.
- 随着sST2水平的提高,LVH和同心缩 (CH) 的患病率增加 (趋势P<0.05).
- 后勤回归表明,sST2的最高三位数与增加的LVH (OR:6.61) 和CH (OR:5.80) 风险显著相关. ROC分析表明sST2对LVH和CH的预测值 (AUC~0.752).
结论:
- 高的sST2水平与EH患者的LVH和CH有很强的相关性.
- sST2显示出作为高血压心脏病的诊断和风险评估生物标志物的潜力.
- 这些发现强调了sST2在治疗患有基本高血压和相关心脏病的患者中的临床实用性.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121